Go Pro
→ A new income category is drawing serious money - here's why (From Investors Alley) (Ad)tc pixel Free SVA Stock Alerts

Sernova (SVA) Competitors

Sernova logo
C$0.12 +0.01 (+4.55%)
As of 10:58 AM Eastern
Compare

SVA vs. HBP, SCYB, COM, NVH, and COV

Should you buy Sernova stock or one of its competitors? Sernova's main competitors and comparable companies include Helix BioPharma (HBP), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), and Covalon Technologies (COV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Sernova compare to Helix BioPharma?

Helix BioPharma (TSE:HBP) and Sernova (TSE:SVA) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation.

0.0% of Helix BioPharma shares are held by institutional investors. Comparatively, 0.0% of Sernova shares are held by institutional investors. 2.2% of Helix BioPharma shares are held by insiders. Comparatively, 12.1% of Sernova shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Helix BioPharma is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Helix BioPharmaN/AN/A-C$50.55M-C$0.04N/A
SernovaN/AN/A-C$35.70M-C$0.04N/A

In the previous week, Helix BioPharma had 1 more articles in the media than Sernova. MarketBeat recorded 1 mentions for Helix BioPharma and 0 mentions for Sernova. Helix BioPharma's average media sentiment score of 0.75 beat Sernova's score of 0.00 indicating that Helix BioPharma is being referred to more favorably in the media.

Company Overall Sentiment
Helix BioPharma Positive
Sernova Neutral

Sernova's return on equity of 55.85% beat Helix BioPharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Helix BioPharmaN/A -21.54% -279.98%
Sernova N/A 55.85%-119.26%

Helix BioPharma has a beta of 0.433836, meaning that its stock price is 57% less volatile than the broader market. Comparatively, Sernova has a beta of -0.460559, meaning that its stock price is 146% less volatile than the broader market.

Summary

Sernova beats Helix BioPharma on 6 of the 9 factors compared between the two stocks.

How does Sernova compare to Scythian Biosciences?

Sernova (TSE:SVA) and Scythian Biosciences (CVE:SCYB) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk.

0.0% of Sernova shares are held by institutional investors. 12.1% of Sernova shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SernovaN/AN/A-C$35.70M-C$0.04N/A
Scythian BiosciencesN/AN/AN/AN/AN/A

In the previous week, Sernova's average media sentiment score of 0.00 equaled Scythian Biosciences'average media sentiment score.

Company Overall Sentiment
Sernova Neutral
Scythian Biosciences Neutral

Sernova's return on equity of 55.85% beat Scythian Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
SernovaN/A 55.85% -119.26%
Scythian Biosciences N/A N/A N/A

Summary

Sernova beats Scythian Biosciences on 3 of the 4 factors compared between the two stocks.

How does Sernova compare to 138267 (COM.TO)?

138267 (COM.TO) (TSE:COM) and Sernova (TSE:SVA) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment.

In the previous week, 138267 (COM.TO)'s average media sentiment score of 0.00 equaled Sernova'saverage media sentiment score.

Company Overall Sentiment
138267 (COM.TO) Neutral
Sernova Neutral

Sernova's return on equity of 55.85% beat 138267 (COM.TO)'s return on equity.

Company Net Margins Return on Equity Return on Assets
138267 (COM.TO)N/A N/A N/A
Sernova N/A 55.85%-119.26%

0.0% of Sernova shares are held by institutional investors. 12.1% of Sernova shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
138267 (COM.TO)N/AN/AN/AN/AN/A
SernovaN/AN/A-C$35.70M-C$0.04N/A

Summary

Sernova beats 138267 (COM.TO) on 3 of the 4 factors compared between the two stocks.

How does Sernova compare to Novoheart?

Sernova (TSE:SVA) and Novoheart (CVE:NVH) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, dividends, institutional ownership, media sentiment, risk and profitability.

In the previous week, Sernova's average media sentiment score of 0.00 equaled Novoheart'saverage media sentiment score.

Company Overall Sentiment
Sernova Neutral
Novoheart Neutral

Novoheart has higher revenue and earnings than Sernova. Novoheart is trading at a lower price-to-earnings ratio than Sernova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SernovaN/AN/A-C$35.70M-C$0.04N/A
NovoheartC$423.50K236.08-C$7.17M-C$0.04N/A

Sernova's return on equity of 55.85% beat Novoheart's return on equity.

Company Net Margins Return on Equity Return on Assets
SernovaN/A 55.85% -119.26%
Novoheart N/A N/A N/A

0.0% of Sernova shares are owned by institutional investors. 12.1% of Sernova shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Sernova and Novoheart tied by winning 4 of the 8 factors compared between the two stocks.

How does Sernova compare to Covalon Technologies?

Covalon Technologies (CVE:COV) and Sernova (TSE:SVA) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, media sentiment, analyst recommendations and earnings.

Covalon Technologies has a net margin of 12.78% compared to Sernova's net margin of 0.00%. Sernova's return on equity of 55.85% beat Covalon Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Covalon Technologies12.78% 15.04% -3.25%
Sernova N/A 55.85%-119.26%

Covalon Technologies has a beta of 1.230106, suggesting that its share price is 23% more volatile than the broader market. Comparatively, Sernova has a beta of -0.460559, suggesting that its share price is 146% less volatile than the broader market.

Covalon Technologies has higher revenue and earnings than Sernova. Sernova is trading at a lower price-to-earnings ratio than Covalon Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Covalon TechnologiesC$32.68M2.54C$2.39MC$0.1618.75
SernovaN/AN/A-C$35.70M-C$0.04N/A

In the previous week, Covalon Technologies had 3 more articles in the media than Sernova. MarketBeat recorded 3 mentions for Covalon Technologies and 0 mentions for Sernova. Covalon Technologies' average media sentiment score of 0.08 beat Sernova's score of 0.00 indicating that Covalon Technologies is being referred to more favorably in the media.

Company Overall Sentiment
Covalon Technologies Neutral
Sernova Neutral

0.2% of Covalon Technologies shares are owned by institutional investors. Comparatively, 0.0% of Sernova shares are owned by institutional investors. 48.7% of Covalon Technologies shares are owned by insiders. Comparatively, 12.1% of Sernova shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Covalon Technologies beats Sernova on 11 of the 12 factors compared between the two stocks.

Get Sernova News Delivered to You Automatically

Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SVA vs. The Competition

Export
MetricSernovaBiotechnology IndustryHealthcare SectorTSE Exchange
Market CapC$43.43MC$3.99BC$7.20BC$12.38B
Dividend Yield7.86%3.61%2.53%6.24%
P/E Ratio-2.8812.25272.6339.34
Price / SalesN/A1,326.16616.739.80
Price / Cash6.15105.2976.9882.29
Price / Book-4.1916.1912.854.68
Net Income-C$35.70M-C$22.72MC$3.47BC$299.09M
7 Day Performance4.55%-1.18%-0.22%-1.51%
1 Month Performance4.55%12.75%8.04%4.09%
1 Year Performance-34.29%53.86%25.08%27.89%

Sernova Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SVA
Sernova
N/AC$0.12
+4.5%		N/A-37.1%C$43.43MN/AN/A1,959
HBP
Helix BioPharma
N/AC$1.90
-2.1%		N/A+31.6%C$145.12MN/AN/A9
SCYB
Scythian Biosciences
N/AC$3.49
-5.9%		N/A+0.0%C$102.38MN/AN/AN/A
COM
138267 (COM.TO)
N/AN/AN/AN/AC$102.19MN/AN/AN/A
NVH
Novoheart
N/AC$0.53
+1.9%		N/A+0.0%C$99.98MC$423.50KN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:SVA) was last updated on 9/2/2026 by MarketBeat.com Staff.
From Our Partners
Under $1… and Wall Street already knows about it
On August 19th, Bitcoin exploded 23% in a matter of days… triggering nearly $3 billion in short liquidations, ...
Crypto 101 Media | Sponsoredtc pixel
Gold Explorer Sits Between Barrick’s Nevada Giants
Barrick Mining has spent decades building one of Nevada's richest gold districts, anchored by Fourmile, Goldru...
Wall Street Logic | Sponsoredtc pixel
Bank of America: 'Digital Dollar Inevitable'
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
A weekly dividend fund holding Nvidia and Palantir
CrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...
Investors Alley | Sponsoredtc pixel
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press | Sponsoredtc pixel
Why Boston Ships In Natural Gas It Already Has at Home
A tanker called the Iberica Knutsen once sailed 2,272 miles from Trinidad and Tobago to deliver liquefied natu...
Porter & Company | Sponsoredtc pixel
#1 Stock to Own as Trump Launches Historic Mission Backing "Medical AI"
The federal government is throwing its full support behind a new class of AI technology, in what's being calle...
Stansberry Research | Sponsoredtc pixel